Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
187.50
+1.50 (0.81%)
At close: Feb 27, 2026

Xvivo Perfusion AB Market Cap

Xvivo Perfusion AB has a market cap or net worth of 5.91 billion as of February 27, 2026. Its market cap has decreased by -60.32% in one year.

Market Cap
5.91B
Enterprise Value
5.74B
Revenue
812.17M
Ranking
n/a
PE Ratio
234.72
Stock Price
187.50

Market Cap Chart

Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.91B, an increase of 1,488.99%. That is a compound annual growth rate of 22.93%.

History

DateMarket Cap% Change
Feb 27, 20265.91B0.48%
Dec 30, 20255.88B-61.84%
Dec 30, 202415.40B48.41%
Dec 29, 202310.38B90.12%
Dec 30, 20225.46B-33.55%
Dec 30, 20218.22B-8.90%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
MedCap AB 6.97B
CellaVision AB 3.57B
Vitrolife AB 12.26B
Nolato AB 13.90B
Elekta AB 21.76B
BICO Group AB 1.27B
Paxman AB 1.19B
Sectra AB 34.80B
Market Cap Rankings